Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q4
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
4T
TIDAL BASIN ADVISORS, INC. for YC CONSULTING, LLC ON BEHALF OF PATIENTS RISING NOW
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Defense, Health Issues, Pharmacy
View →
4T
JEFFREY J. KIMBELL & ASSOCIATES, INC. for ENDO USA, INC., A MALLINCKRODT-ENDO COMPANY
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $20,000.00 income
Health Issues, Pharmacy
View →
4T
BROWNSTEIN HYATT FARBER SCHRECK, LLP for WALGREEN CO.
4th Quarter (Oct 1 - Dec 31) 2025 · Illinois · $50,000.00 income
Pharmacy
View →
Q4
KOUNTOUPES DENHAM CARR & REID, LLC for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Health Issues
View →
Q4
ARNOLD & PORTER KAYE SCHOLER LLP for NOVO NORDISK, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $70,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
Q4
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $245,484.00 income
Health Issues, Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q4
KOUNTOUPES DENHAM CARR & REID, LLC for CENCORA INC. (FORMERLY AMERISOURCEBERGEN CORPORATION)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues, Pharmacy, Defense, Taxation/Internal Revenue Code
View →
Q4
SQUIRE PATTON BOGGS for SK AMERICAS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $110,000.00 income
Environment/Superfund, Pharmacy, Science/Technology, Taxation/Internal Revenue Code
View →
Q4
BURRELL INTERNATIONAL GROUP LLC for TONIX PHARMACEUTICALS HOLDING CORP.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
BURRELL INTERNATIONAL GROUP LLC for SHIONOGI INC.
4th Quarter (Oct 1 - Dec 31) 2025 · New Jersey · House · Senate · $40,000.00 income
Pharmacy
View →
Q4
TSG ADVOCATES DC, LLC for BELCHER PHARMACEUTICALS LLC
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate · $60,000.00 income
Pharmacy, Government Issues
View →
Q4
KOUNTOUPES DENHAM CARR & REID, LLC for AMERICAN KRATOM ASSOCIATION
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate · $50,000.00 income
Consumer Issues/Safety/Products, Health Issues, Pharmacy, Budget/Appropriations
View →
RA
BROWNSTEIN HYATT FARBER SCHRECK, LLP for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia
Manufacturing, Pharmacy, Trade (domestic/foreign)
View →
RR
RUBIN, TURNBULL & ASSOCIATES for ASSOCIATION FOR ACCESSIBLE MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia
Pharmacy, Health Issues
View →
Q4
VERTEX PHARMACEUTICALS INCORPORATED for VERTEX PHARMACEUTICALS INCORPORATED
4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Budget/Appropriations
View →
Q4
WAXMAN STRATEGIES for 340B HEALTH
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $39,000.00 income
Health Issues, Pharmacy
View →
Q4
BROYDRICK & ASSOCIATES for TONIX PHARMACEUTICALS
4th Quarter (Oct 1 - Dec 31) 2025 · New York · House · Senate · $20,000.00 income
Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for TRAVERE THERAPEUTICS, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · $30,000.00 income
Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for SAVARA INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for REGENXBIO INC.
4th Quarter (Oct 1 - Dec 31) 2025 · Maryland · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q4
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
4th Quarter (Oct 1 - Dec 31) 2025 · Delaware · House · Senate · $70,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q4
LMH STRATEGIC SOLUTIONS for HARMONY BIOSCIENCES
4th Quarter (Oct 1 - Dec 31) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Previous Page 13 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem